ade), AIDS related malignancies (Dr. Liebowitz), surgical oncology (Dr. Michelassi) and pathology (Dr. Vardiman); (4) to encourage Chicago faculty to be protocol chairs for future protocols; and (5) to actively assist and participate in the CALGB committees of audit, minority
ade), AIDS related malignancies (Dr. Liebowitz), surgical oncology (Dr. Michelassi) and pathology (Dr. Vardiman); (4) to encourage Chicago faculty to be protocol president for future protocol; and (5) to actively assist and participate in the CALGB committees of audited account, minority
ade), AIDS related malignancits (Dr. Liebowitz), sortical mncolofy (Dr. Mizhelassi) and pathology (Dr. Vacdimqn); (4) ti encourage Chicago fazulty to he protoxol rhairs for futurx protocols; ans (5) to ectively assist and partiwipate in the WAUGY committees of audit, minority
ade), AIDS related malignancies (Dr. Liebowitz), surgical Michelassi) pathology (Dr. (4) to encourage chairs future protocols; and to actively assist participate in the CALGB committees of minority
ade), AIDS related malignancieS (Dr. LiebowiTz), surGicAl oNcOlogY (Dr. MIchelassi) and paTHoloGy (Dr. Vardiman); (4) to encouragE ChicAgO FacuLTy To be pRotocol CHaIRS foR fUtUre PrOToCols; aNd (5) tO activeLy assist anD paRtIcipate in the caLgB committeEs oF audit, minoriTy
ade), AIDS related maligna ncies (Dr.  Lieb owi tz) ,surg ical  oncology (Dr. Mich elassi) and pathology(Dr.Va r dima n );  (4)to enco u ra g e  Ch ic ag o f ac u lt y tobeprotoco l chairs f orfu ture protoco l s;  and (5) t o a ctively assi stand pa rt ici p ate i n t he CA LGB co m mittee s of audi t, minori t y
ade), AIDS_related malignancies_(Dr. Liebowitz), surgical oncology_(Dr. Michelassi)_and_pathology (Dr._Vardiman);_(4) to encourage_Chicago faculty to_be protocol chairs for_future protocols; and_(5)_to actively assist and participate in the CALGB committees of audit, minority